GAMCO Asset Management »

Tourmaline Bio shares owned by GAMCO Asset Management

Quarter-by-quarter ownership of Tourmaline Bio (TRML) shares owned by GAMCO Asset Management from 13F filings

Historical chart of GAMCO Asset Management investment in Tourmaline Bio

Tip: Access up to 7 years of quarterly data

All positions including Tourmaline Bio held by GAMCO Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tourmaline Bio by GAMCO Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $478k 10k 47.83

More positions owned by GAMCO Asset Management

Mueller Industries Equity (MLI)
Gatx Corp Equity (GATX)
Crane Equity (CR)
Sony Group Corp - Sp Depository Recei (SONY)
American Express Equity (AXP)
Bank Of New York Mellon Corp Equity (BK)
Modine Manufacturing Equity (MOD)
Madison Square Garden Sports Equity (MSGS)
National Fuel Gas Equity (NFG)
Herc Holdings Equity (HRI)
Watts Water Technologies-a Equity (WTS)
Textron Equity (TXT)
Ametek Equity (AME)
Republic Services Equity (RSG)
Atlanta Braves Hlds A In-a Equity (BATRA)

View all positions for GAMCO Asset Management

Top funds holding Tourmaline Bio

venBio Select Advisor
QVT Financial
BlackRock
TCG Crossover Management
Pfizer
Vanguard Group
Fil
Magnetar Financial
Qiming U.S. Ventures Management
Vivaldi Asset Management
TIG Advisors
Vivo Capital
Alliancebernstein
Highland Capital Management Fund Advisors
Geode Capital Management

View all funds holding Tourmaline Bio